PharmaLundensis
Pre-clinicalPharmaLundensis develops drugs that bind and excrete heavy metals such as mercury, lead and cadmium from the body. This is expected to bring significant health improvements in a number of diseases.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Funding information not available
About
PharmaLundensis develops drugs that bind and excrete heavy metals such as mercury, lead and cadmium from the body. This is expected to bring significant health improvements in a number of diseases.
Small Molecules